UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

B cells in the pathogenesis of primary Sjögren syndrome

Nature reviews. Rheumatology, 2018-03, Vol.14 (3), p.133

2018

Volltextzugriff (PDF)

Advances in understanding the pathogenesis of primary Sjögren's syndrome

Nature reviews. Rheumatology, 2013-09, Vol.9 (9), p.544

2013

Volltextzugriff (PDF)

Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management

British journal of haematology, 2015-02, Vol.168 (3), p.317-327

2015

Volltextzugriff (PDF)

Current and future therapies for primary Sjögren syndrome

Nature reviews. Rheumatology, 2021-08, Vol.17 (8), p.475-486

2021

Volltextzugriff (PDF)

Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma

Rheumatology (Oxford, England), 2021-08, Vol.60 (8), p.3513-3521

2021

Volltextzugriff (PDF)

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

Annals of the rheumatic diseases, 2015-03, Vol.74 (3), p.526-531

2015

Volltextzugriff (PDF)

Adult-onset Still’s disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?

Rheumatology (Oxford, England), 2022-05, Vol.61 (6), p.2535-2547

2022

Volltextzugriff (PDF)

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

Annals of the rheumatic diseases, 2024-03, Vol.83 (3), p.407

2024

Volltextzugriff (PDF)

Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study

Rheumatology (Oxford, England), 2015-12, Vol.54 (12), p.2249-2256

2015

Volltextzugriff (PDF)

Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors

The Journal of immunology (1950), 2019-10, Vol.203 (7), p.1766-1775

2019

Volltextzugriff (PDF)

Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al

Arthritis care & research (2010), 2022-01, Vol.74 (1), p.162-162

2022

Volltextzugriff (PDF)

Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.133

2018

Volltextzugriff (PDF)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis

Frontiers in immunology, 2022-02, Vol.13, p.832117-832117

2022

Volltextzugriff (PDF)

Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab

Rheumatology (Oxford, England), 2020-11, Vol.59 (11), p.3275-3283

2020

Volltextzugriff (PDF)

Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy

Rheumatology (Oxford, England), 2020-06, Vol.59 (6), p.1347-1354

2020

Volltextzugriff (PDF)

Erratum to: Adult-onset Still’s disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.882-882

2022

Volltextzugriff (PDF)

Interferon signature in systemic autoimmune diseases: what does it mean?

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002687

2022

Volltextzugriff (PDF)

Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.933-940

2016

Volltextzugriff (PDF)

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation

Journal of allergy and clinical immunology, 2016-06, Vol.137 (6), p.1809-1821.e12

2016

Volltextzugriff (PDF)

Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients

Rheumatology (Oxford, England), 2022-08, Vol.61 (9), p.3818-3823

2022

Volltextzugriff (PDF)

JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis

Cellular & molecular immunology, 2020-05, Vol.17 (5), p.552-553

2020

Volltextzugriff (PDF)

Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2016-05, Vol.68 (5), p.1245-1250

2016

Volltextzugriff (PDF)

Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas

Journal of autoimmunity, 2017-06, Vol.80, p.56-64

2017

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

B cells in the pathogenesis of primary Sjögren syndrome

Advances in understanding the pathogenesis of primary Sjögren's syndrome

Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management

Current and future therapies for primary Sjögren syndrome

Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

Adult-onset Still’s disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study

Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors

Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al

Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis

Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab

Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy

Erratum to: Adult-onset Still’s disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort

Interferon signature in systemic autoimmune diseases: what does it mean?

Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis

Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients

JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis

Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome

Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas

Suchergebnisse filtern